Drug Abuse Research Today is a free monthly online journal that collates and summarizes the latest research about Drug Abuse, including details on psychology, rehabilitation, consequences, treatment.

Volume 3 (2007), Issue 9 (September)

1. Global estimates of prevalence of HCV infection among injecting drug users.
   Int J Drug Policy, 18(5): 352-8. [Abstract] [Full-text]
2. Recruitment and follow-up of injecting drug users in the setting of early hepatitis C treatment: insights from the ATAHC study.
   Int J Drug Policy, 18(5): 447-51. [Abstract] [Full-text]
3. Treatment uptake and outcomes among current and former injection drug users receiving directly observed therapy within a multidisciplinary group model for the treatment of hepatitis C virus infection.
   Int J Drug Policy, 18(5): 437-43. [Abstract] [Full-text]
4. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
   Int J Drug Policy, 18(5): 417-25. [Abstract] [Full-text]
5. Integrating HCV services for drug users: a model to improve engagement and outcomes.
   Int J Drug Policy, 18(5): 406-10. [Abstract] [Full-text]
6. Hepatitis C meanings and preventive strategies among street-involved young injection drug users in Montréal.
   Int J Drug Policy, 18(5): 397-405. [Abstract] [Full-text]
7. Everybody's got it, but...: situational and strategic participation in normalized HCV discourse among injection drug users in Edmonton, Canada.
   Int J Drug Policy, 18(5): 388-96. [Abstract] [Full-text]
8. Prejudice among health care workers toward injecting drug users with hepatitis C: does greater contact lead to less prejudice?
   Int J Drug Policy, 18(5): 381-7. [Abstract] [Full-text]
9. The drugs that dare not speak their name: Injecting and other illicit drug use during treatment for hepatitis C infection.
   Int J Drug Policy, 18(5): 374-80. [Abstract] [Full-text]
10. Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran.
    Int J Drug Policy, 18(5): 359-63. [Abstract] [Full-text]
11. High prevalence of occult hepatitis B virus infection in Taiwanese intravenous drug users.
    J Med Virol, 79(11): 1674-8. [Abstract] [Full-text]
12. Development of a scheduled drug diversion surveillance system based on an analysis of atypical drug transactions.
    Anesth Analg, 105(4): 1053-60, table of contents. [Abstract] [Full-text]
13. Vaccine immunogenicity in injecting drug users: a systematic review.
    Lancet Infect Dis, 7(10): 667-74. [Abstract] [Full-text]

© 2005-2008 Drug Abuse Research Today. All Rights Reserved.